• Explore /
  • Poster
  • / Impact of nirogacestat on pain, a key symptom in patients with desmoid tumors (DT): Results from the phase 3 DeFi study.

Impact of nirogacestat on pain, a key symptom in patients with desmoid tumors (DT): Results from the phase 3 DeFi study.

Abstract Video & Slides Poster

Authors

Winette T.A. Van Der Graaf

Winette T.A. Van Der Graaf

Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands

Winette T.A. Van Der Graaf , Mrinal M. Gounder , Ravin Ratan , Cristina Ivanescu , James Marcus , Timothy Bell , Allison Lim , L. Mary Smith , Ana Belen Oton , Thierry Alcindor , Patrick Schöffski , Breelyn A. Wilky , Richard F. Riedel , Charlotte Benson , Nam Bui , Rashmi Chugh , Shivaani Kummar , Bernd Kasper

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT03785964

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11564)

DOI

10.1200/JCO.2023.41.16_suppl.11564

Abstract #

11564

Poster Bd #

498

Abstract Disclosures

Similar Posters

First Author: Thierry Alcindor

First Author: Antoine Thiery-Vuillemin

First Author: Rongbo Lin

First Author: Rongbo Lin